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Long-term sequelae of acute kidney injury (AKI) are associated with incomplete recovery
of renal function and the development of chronic kidney disease (CKD), which can
be mediated by aberrant innate immune activation, mitochondrial pathology, and
accumulation of senescent tubular epithelial cells (TECs). Herein, we show that the
innate immune receptor Triggering receptor expressed on myeloid cells-1 (TREM-1) links
mitochondrial metabolism to tubular epithelial senescence. TREM-1 is expressed by
inflammatory and epithelial cells, both players in renal repair after ischemia/reperfusion
(IR)-induced AKI. Hence, we subjected WT and TREM1/3 KO mice to different models
of renal IR. TREM1/3 KO mice displayed no major differences during the acute
phase of injury, but increased mortality was observed in the recovery phase. This
detrimental effect was associated with maladaptive repair, characterized by persistent
tubular damage, inflammation, fibrosis, and TEC senescence. In vitro, we observed
an altered mitochondrial homeostasis and cellular metabolism in TREM1/3 KO primary
TECs. This was associated with G2/M arrest and increased ROS accumulation. Further
exposure of cells to ROS-generating triggers drove the cells into a stress-induced
senescent state, resulting in decreased wound healing capacity. Treatment with a
mitochondria anti-oxidant partly prevented the senescent phenotype, suggesting a role
for mitochondria herein. In summary, we have unraveled a novel (metabolic) mechanism
by which TREM1/3 deficiency drives senescence in TECs. This involves redox imbalance,
mitochondrial dysfunction and a decline in cellular metabolic activities. These finding
suggest a novel role for TREM-1 in maintaining tubular homeostasis through regulation
of mitochondrial metabolic flexibility.
Keywords: maladaptive repair, mitochondrial metabolism, tubular cell senescence, epithelial innate immunity,
renal repair, ischemia/reperfusion injury
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INTRODUCTION
Acute kidney injury (AKI) remains a financial burden for
society due to its high morbidity and mortality rates. Recent
epidemiological and clinical studies have linked AKI to an
increased risk of developing chronic kidney disease (CKD) (1).
The ischemic damage experienced during transplant procedures
is a common cause of AKI. The proximal tubular epithelial cells
(TECs), have a high metabolic rate, thus, sensitive to ischemic
injuries (2). As such, being metabolically flexible provides
an important advantage to quickly respond to environmental
changes and ensure a healthy tubular function. Indeed, the renal
epithelium has the ability to regenerate after injury; surviving
TECs enter the cell cycle within a few hours following AKI, in
order to promote tubular proliferation and return to homeostasis
(3–5). This is the so-called “adaptive repair” post-AKI, which
results in the recovery of renal function. However, maladaptive
repair might also occur, as a consequence of cell cycle arrest or
senescence in TECs often accompanied by an increased secretory
phenotype, which contributes to persistent inflammation, loss
of renal function and renal fibrosis (6, 7). Cellular senescence
is an irreversible growth arrest which can be triggered by DNA
damage, oxidative stress, or mitochondrial injury. TECs are
densely packed with mitochondria because of their reabsorptive
functions, which require high energy expenditure. Thus, it
is not surprising that mitochondrial dysfunction in TECs is
thought to be a pathogenic mechanism underlying the AKI-CKD
transition (8–10).
Senescence tubular cells accumulate in diseased and aged
kidney (11). Additionally, in responses to danger signals released
during IR-induced AKI, TEC-associated pattern recognition
receptors (PRRs) function as sentinels to dictate epithelial
inflammation and repair, a regulatory process which might also
be affected during aging.
Triggering Receptor Expressed on Myeloid cells-1 (TREM-
1) is an amplifier of the inflammatory response elicited by
TLR4, and we have previously published that following renal IR,
TREM-1 is upregulated in the early phase of damage, due to the
infiltration of granulocytes, expressing high levels of TREM-1
(12, 13). Similar to the role of TLR4 in renal IR, damage induced
by inflammatory cell-associated TREM-1 plays a dispensable role
in renal IR (12). During sterile inflammation, TLR4 and TREM-1
expression is also detectable on epithelial cells (13, 14). Epithelial
TLR4-mediated inflammation appears detrimental during the
acute phase of injury after renal IR but essential for tubular
regeneration (15, 16). Besides its role in immune regulation,
TREM-1 has also been linked to cell survival and mitochondrial
integrity (17). Given these evidences, we hypothesized that
TREM-1 could play a role in renal repair after AKI. Therefore,
we subjected WT and TREM1/3 double KO animals to renal IR
injury and investigated the tissue repair mechanisms herein. The
TREM1/3 KO mice were chosen as they represent a better model
for translational studies as Trem3 appears to be a pseudogene
in humans.
The present study reports a novel mechanism through
which the immune receptor TREM1/3 maintains tubular
integrity by suppressing senescence programs herein, limiting the
maladaptive repair following IR. TREM1/3 provides TECs with
a metabolic flexibility necessary for proliferation, which favors
renal regeneration after IR.
MATERIALS AND METHODS
Reagents and Antibodies
Rat anti-mouse F4/80 (BD pharmigen), mouse anti-mouse
αSMA (clone 1A4, DAKO), rabbit-polyclonal collagen type
1 (Genetex), rabbit anti-Ki67 (Sp6, Neomarkers), rabbit anti-
cleaved caspase-3 (Cell signaling), goat polyclonal-anti TREM-1
(Santa Cruz), rabbit polyclonal-anti TREM-1 (Abcam), mouse
anti-phosphorylated histone H3 (Phospho S10) (Abcam),
anti-Tom20 (Clone 2Fb.1) (Millipore), anti-p21/WAF/Cip1
(Millipore), rabbit anti-biotinylated TREM-1 antibody (50D1
clone; gift from Colonna Lab), rabbit anti-Mitofusin2 (D2D10)
(Cell signaling), rabbit anti-AMPKα and rabbit anti-phospho-
AMPKα (Cell signaling), rabbit anti-mouse PKM2 (Cell
signaling), anti- mouse Alexa fluor488 (Invitrogen), donkey-
anti-rabbit Alexa 594 (Jackson), hoechst 33342 (Sigma),
streptavidine-APC (BD), mouse KC, MCP-1, sTREM-1 duo-
set Elisa (R&D), streptavidin-HRP (Sanquin), TMB (Sigma),
collagenase from clostridium histolyticum, type 1A (Sigma),
propidium Iodide (Molecular probes), senescence-associated
β-galactosidase (SA-β-Gal) staining kit (cell signaling), C12FDG
(5-Dodecanoylaminofluorescein Di-β-D-Galactopyranoside)
(Invitrogen), fixable viability stain 780 (BD), bafilomycin
A1 from Streptomyces griseus (Sigma), MITO-ID membrane
potential detection kit (Enzo), mitoSOX Red mitochondrial
superoxide indicator (Molecular probes) and ATP determination
kit (Molecular Probes), MitoTEMPO (Sigma), TREM-1 agonist
antibody (R&D).
Murine Models of Renal IR
All animal experiments were approved by the Institutional
Animal Care and Use committee of the University of Amsterdam
and were in compliance with the ARRIVE guidelines (NC3Rs).
Eight-week-old male C57Bl/6J (B6J) mice were purchased by
Charles River. TREM1/3 double KO mice were generated, as
previously described (18), backcrossed to a C57Bl6 background
and bred in the animal facility of the Academic Medical Center
in Amsterdam, The Netherlands. Age- and sex-matched mice
were used. Animals were kept under standard environmental
conditions (temperature, humidity, ventilation, light/dark cycle),
housed in specific pathogen-free conditions (SPF) with ad libitum
access to water and food.
Wild-type (WT) C57BL/6 and TREM-1/3 KO mice (n = 8)
were subjected to severe AKI (bilateral renal IR, 25min
clamping time) or mild AKI (unilateral renal IR, 20min
clamping time), as previously described (12). Under 2.5%
isoflurane-induced anesthesia, mice underwent clamping of the
renal artery for the previously mentioned time periods. Upon
completing surgery, muscle and skin layers were closed with
surgical sutures (6-0, Tyco). Fifty µg/kg buprenorphine was
administered through a subcutaneous injection, for analgesic
purposes (Temgesic Shering-Plow). Animals were sacrificed via
cardiac exsanguination followed by cervical dislocation, at day
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1, 5, and 10 post-surgery. Sham mice were sacrificed at day
one and used as control for mild AKI experiment. Contralateral
kidneys from mild AKI experiment, were used as controls for
PKM2 staining.
For the isolation of primary proximal TECs, we used a
well-established protocol from our department (19). Briefly,
kidneys were removed and stored on ice in Hank’s Balanced
Salt Solution (HBSS), supplemented with 50U penicillin and
50µg/ml streptomycin. After removal of the renal capsule, tissue
was minced with scalpels. A single-cell suspension was obtained
by means of collagenase IV digestion. Cells were strained over a
70- and 40-µm filter mesh and cultured in HK-2 medium (see
below) under standard culture conditions.
Cell Culture and Hypoxia/Reoxygenation
Experiment
Cells were cultured in HK-2 medium (DMEM/F12 medium,
supplemented with 10% FBS, 5µg/ml insulin and transferrin,
5 ng/ml sodium selenite, 20 ng/ml triiodo-thyrionine, 50 ng/ml
hydrocortisone, and 5 ng/ml prostaglandin E1 with l-glutamine
and antibiotics). IM-TECs were cultured at 33◦C in the presence
of 10 ng/ml IFN-γ (ProSpec) and kept at 37◦C without IFN-γ for
another week before the start of the experiment (20). Primary
TECs were isolated and cultured as described above (21).
Hypoxia/reoxygenation experiments were performed as
follows. Cells (IM-TECs or primary TECs) were cultured
until confluency, incubated in complete medium in the
HypOxystation H35 (Don witley scientific) and cultured for
2 days in 1% Oxygen, 5% CO2 at 37◦C, in order to mimic
the hypoxic condition. Cell viability was assessed with the
MTT staining (data not shown). Normoxic cells were kept in
culture under standard conditions. After 2 days of hypoxia,
both hypoxic and normoxic cells received fresh medium and
were cultured for an additional 24 h under standard conditions
(re-oxygenation). MitoTEMPO (100µM) or TREM-1 agonist
(mTREM-1: 10µg/ml) were added in the culture media during
the re-oxygenation time (24 h).
In vitro Assays
All in vitro assays were performed in primary TECs fromWT and
TREM-1/3 KOmice (n= 5–7) and 5–6 replicates were examined
per animal.
Cellular oxygen consumption rate (OCR) was determined in
primary and immortalized TECs plated on a PureCol coated XF
96 well assay plate, one day prior to the assay. OCR data were
determined with the XFe96 Extracellular flux analyzer (seahorse
bioscience) using the XF Cell Mito Stress Test which was used
according to the provided protocols. Briefly, cells were incubated
in assay medium (DMEM phenol red, 25mM D-glucose, 1mM
Na pyruvate, 2mM glutamine, adjusted to pH 7.4) at 37◦C in
a non-CO2 incubator for 1 h prior to metabolic measurement.
During the metabolic assay, oxygen consumption rates were
measured over time at basal level and after the consequential
addition of oligomycin (1.5µM), FCCP (1µM), and rotenone
(1.25µM) together with antimycin A (2.5µM). The indicated
compound concentrations are final concentration in assay
medium. OXPHOS parameter calculations are according to the
Mito stress test provided by Agilent. The following parameters
were assessed as described: basal respiration (difference between
basal OCR and OCR after addition of oligomycin A+rotenone),
ATP-linked respiration (difference in OCR before and after
oligomycin addition), maximal respiration (OCR after FCCP
minus OCR after oligomycin A+rotenone), spare respiratory
capacity (difference between maximal and basal OCR), non-
mitochondrial respiration (OCR rate after last injection of
oligomycin A+rotenone), and H+ (proton) leak (difference
in OCR after oligomycin addition and non-mitochondrial
respiration). After the run, supernatant was carefully aspirated
and crystal violet cell staining was performed to normalize the
values based on cell input. Cells were stained with 0.4% crystal
violet in methanol, washed with deionized water, and eluted
with methanol. Absorbance of crystal violet was measured at
570 nm (19).
For ATP cell measurements, primary TECs were subjected
to hypoxia/reoxygenation. ATP levels were detected with a kit,
according to the manufacturer’s protocol and adjusted for cell
input by total protein concentration, as determined by BCA.
To examine the effect of hypoxia/reoxygenation on
mitochondrial superoxide production, primary TECs were
labeled with 5µM MitoSOX Red in HBSS, supplemented with
calcium and magnesium (Gibco), for 10min in the dark at 37◦C.
Relative fluorescence was measured by FACS.
For the measurement of mitochondrial membrane polarity,
primary TECs were plated in black 96-well Clear plates
(Greiner) and subjected to hypoxia/re-oxygenation experiments
as described above. Mitochondrial polarity was determined using
the MITO-ID Membrane potential cytotoxicity kit (Enzo Life
Sciences), which uses a cationic dual-emission dye. The dye
emits green fluorescence at∼530 nm when present in the cytosol
as a monomer; once the dye enters polarized mitochondria,
it forms aggregates which shift the emitted light from 530 to
570 nm. Dual fluorescence was measured using the CLARIOstar
plate reader. Data are expressed as the ratio between the red
fluorescence (mitochondria) (514 nm Ex/590 nm Em) and green
fluorescence (cytoplasm) (514 nm Ex/529 nm Em), as previously
described (22).
Flow Cytometry Analysis (FACS)
To determine TREM-1 expression on proximal TECs, cells were
detached by treatment with trypsin, washed and suspended in
staining buffer (PBS without Ca2+ Mg2+, 0.5% BSA, 2mM
EDTA, 0.025% NaN3). Trypsin digestion did not affect TREM-
1 surface expression, as observed in blood-derived granulocytes
(data not shown). Anti-CD16/32 (clone 24G2) was added for
10min to prevent non-specific, Fc-mediated, binding. Cells
were then incubated with biotinylated-anti-TREM-1 Ab (gift
from Colonna lab), followed by staining with streptavidin-APC.
Propidium Iodide was added prior to acquisition for dead/live
staining. Samples were analyzed using the FACSCanto II flow
cytometer (BD Biosciences) and data were analyzed using FlowJo
7.6 software (TreeStar).
SA-β-Galactosidase
Microscopy: frozen kidney tissue or cells cultured on coverslips
were used for microscopic analysis. Fixation and staining was
performed with the SA-β-Gal staining kit, according to the
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manufacture’s protocol. Senescent cells were identified as blue-
stained cells by standard light microscopy. Quantification of
positive staining was performed with Image Pro Premier (vs. 9.3;
Media Cybernatics, Rockville, MD, USA). We used the smart
segmentation approach to segment the immunopositive area,
which is expressed as a percentage of the total tissue surface
(area). The percentage of the immunopositive area was calculated
in images of 10 non-overlapping HPFs, per slide (n= 5).
Activity: SA-β-Gal activity was measured by means of a
flow cytometric assay, using the fluorogenic substrate C12FDG
(Invitrogen), as previously described (23). Briefly, cells were
previously incubated with Fixable Viability Stain 780 in order
to exclude dead cells, followed by incubation with Bafilomycin
at 37◦C for 1 h. β-gal substrate was incubated for another hour
at 37◦C. Cells were washed with PBS and acquired with a FACS
Canto II (BD).
Determination of Intracellular Metabolite
Abundance by LC-MS (Metabolomics)
Primary TECs isolated from WT and TREM1/3 KO mice
(n = 6/5), seeded at equal density and cultured for 72 h, were
used for metabolomics experiments, which were performed at
the Metabolomics Core Facility of the Academic Medical Center,
University of Amsterdam. Procedure is explained below.
Cells were washed with ice-cold PBS and metabolism was
quenched by adding 1mL of ice-cold methanol followed by 1mL
of ice-cold water. Cells were collected by scraping. The samples
were incubated in a sonication bath and sonicated for 15min.
The homogenate was transferred to a 2mL tube and 1mL of
chloroform was added, after which the homogenate was vortexed
and centrifuged for 5min at 14,000 rpm at 4◦C. The “polar”
top layer was transferred to a new 1.5mL tube and dried in a
vacuum concentrator. Dried samples were dissolved in 100 µL
methanol/water (6/4; v/v).
For the analysis, a Thermo Scientific ultra-high pressure
liquid chromatography system (Waltman) coupled to Thermo
Q Exactive (Plus) Orbitrap mass spectrometer (Waltman) was
used. The autosampler was held at 10◦C during the runs and
5 µL sample was injected onto the analytical column. The
chromatographic separation was established using a SeQuant
ZIC-cHILIC column (PEEK 100 x 2.1mm, 3.0µm particle size,
Merck) and kept at 15◦C. The flow rate was 0.250 mL/min. The
mobile phase was composed of (A) 9/1 acetonitrile/water with
5mM ammonium acetate; pH 6.8 and (B) 1/9 acetonitrile/water
with 5mM ammonium acetate; pH 6.8. The LC gradient program
was as follows: beginning with 100% (A) hold 0–3min; ramping
3–24min to 20% (A); hold from 24 to 27min at 20% (A); ramping
from 27 to 28min to 100% (A); and re-equilibrate from 28 to
35min with 100% (A). The MS data were acquired in negative
mode at full scan range at 140,000 resolution. Interpretation of
the data was performed in the Xcalibur software (Thermo Fisher).
Wound Healing Assay
Primary TECs from WT and TREM1/3 KO animals (n =
5) were isolated, cultured and subjected to in vitro IR, as
described above. Subsequently, a scratch was made using a
p100 pipette tip and cells were monitored for the following
24 h, using a live cell phase-contrast microscope (Leica
DMi8). Settings were adjusted with LasX software (Leica).
Recovery was assessed by an in-house developed method
(CiMicro software), which measures the surface of the wound
area (in pixels).
Stable Gene Silencing by sgRNA
Stable knockout cells were generated by CRISP/Cas9 technology;
IM-TECs were transduced with lentiviral particles harboring
single guide RNA (sgRNA) for 24 h, in the presence of 8µg/ml
polybrene (Sigma Aldrich). Puromycin (Sigma Aldrich) selection
was initiated 48 h after transduction.
Lentiviral particles were produced by transfecting HEK293T
cells, using GENIUS DNA Transfection Reagent (Westburg),
with the following vectors: pMD2.G/VSVG (Addgene 12259),
pPAX2 (Addgene 12260), and pLentiCRISPRv2 (Addgene 52961)
at a DNA ratio of 6:15:20 µg DNA ratio, respectively.
Single guide RNA (sequence: CTTCCATCCTGTCCGCCTGG)
targeting murine TREM-1 was inserted into the lentiviral
vector pLentiCRISPRv2, according to the protocol described by
Sanjana et al. (24).
BrDU Incorporation Assay
For Cell-cycle analysis, cells were incubated for 1 h with 20µM
BrdU (Sigma Aldrich) and subsequently fixed in 70% ice-cold
ethanol. Cells were processed as described previously in our
department (25). Staining with anti-BrdU FITC (clone B44; BD)
was performed in buffer, containing 0.05% Tween-20/0.5% BSA
in PBS. After washing, cells were stained with 0.1µM TO-
PRO-3-iodide (Invitrogen Life Technologies) in PBS/0.5% BSA,
containing 500µg/mL of RNAse-A (Bioke), for 15min at 37◦C.
Cell-cycle distribution was analyzed by flow cytometry.
Protein Determination by ELISA and
Western Blot
The levels of KC, MCP-1, and soluble TREM-1 protein (sTREM-
1) were measured by ELISA in kidney homogenates. Plasma
levels of sTREM-1 were also measured. Frozen renal tissues
were processed in Greenberger lysis buffer (150mM NaCl,
15mM Tris, 1mM MgCl2 pH 7.4, 1mM CaCl2, 1% Triton x-
100), supplemented with 1% protease inhibitor cocktail (Sigma-
Aldrich, Zwijndrecht, The Netherlands). Renal TREM-1, KC and
MCP-1 levels were adjusted for total protein concentration, as
measured by BCA (Thermo Fischer).
For tissue protein isolation, 30 µM—thick, frozen kidney
slices were used. Tissue and cells were lysed in RIPA buffer
(50mM Tris pH7.5, 0.15M NaCl, 2mM EDTA, 1% deoxycholic
acid, 1% NP-40, 4mM sodium orthovanadate, 10mM sodium
fluoride), supplemented with 1% protease inhibitor cocktail
(Sigma-Aldrich). Lysates were loaded onto a 4–12% Nupage gel
and blotted onto a PVDF membrane. After blocking aspecific
signal, blots were incubated overnight with primary antibodies.
Blots were incubated with horseradish-peroxidase-conjugated
secondary antibodies and detected with ECL (Pierce).
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Histology, (Immuno)-Histochemistry, and
Microscopy
Paraffin-embedded kidney tissue, was fixed in 4% formalin for
24 h before processing. For (immuno) histological examination,
4 µM-thick paraffin sections were used. The tubular injury score
was determined in PAS-D-stained sections, by a pathologist,
in a blinded manner, using a 5-point scale that is based
on the presence of necrosis, as previously described (26).
Immunohistochemical staining was performed for the detection
of macrophages, myofibroblasts, collagen deposits, glycolysis,
proliferating, and apoptotic TECs. Sections were processed for
antigen retrieval followed by overnight incubation with primary
antibodies, at 4◦C. The following day, slides were incubated
with peroxidase-conjugated secondary antibodies for 30min
and stained with 3,3-diaminobenzidine (DAB). The amount
of positive staining for F4/80, αSMA, collagen I and PKM2
was quantified with ImageJ software, Fiji (NIH), a computer-
based imaging analysis for reliable biomarker quantitation.
Proliferating TECs were counted in the cortico-medullary region
in 10 randomly chosen non-overlapping HPFs (magnification
20X). For fluorescent microscopy, cells cultured on coverslips
were used. Primary and secondary antibody labeling was
performed in 0.5% BSA and 0.1% Triton X-100. Secondary
antibodies were detected with either Texas Red or Alexa fluor-
labeled antibodies. Cells were counterstained with Hoechst 33342
for nuclear staining (Sigma). Fluorescencemicroscopy and image
acquisition was performed on a Leica DM5000B using the
LAS acquisition software (Leica). Percentage of pH3 nuclei was
determined by counting total and pH3 positive nuclei in a
blinded fashion.
RT-PCR
Total RNA was extracted from frozen kidneys using Trizol-
reagent (Sigma-Aldrich). cDNA was synthesized using M-MLV
reverse transcriptase and oligo-dT primers. Transcript analysis
was performed by real-time quantitative PCR on the Roche
Light Cycler 480 using SYBR green master mix (Bioline).
Relative expression was analyzed using LinRegPCR (developed
by Hearth failure research center, University of Amsterdam,
the Netherlands). Gene expression was normalized to murine
Peptidylprolyl Isomerase A (Ppia) and Tata Box binding Protein
(Tbp) housekeeping genes. Murine primer sequences are listed in
Supplementary Table 1.
Statistics
For in vivo experiments, comparisons between 2 groups were
analyzed using Mann-Whitney U-test. Comparisons between
more than 2 groups were analyzed with the Kruskal-Wallis test
followed by Dunn’s multiple comparisons test. Survival curves
were analyzed by the Log-rank (Mantel-Cox) test. For in vitro
experiments, comparisons between two groups were analyzed
using the two-tailed student’s t-test. Values are expressed as mean
± standard error of the mean (S.E.M). P < 0.05 were considered
statistically significant.
RESULTS
TREM1/3 Limits Maladaptive Renal Repair
We have previously described TREM-1 increase in plasma and
kidney 1 day post-bilateral clamping of renal artery, which
induces a severe AKI response (12). Here, we show that TREM-
1 levels in plasma increase as well 5 days post-bilateral IR
(Figure 1A). Additionally, renal TREM-1 expression increased
during the recovery (t = 5) and resolutive phases (t = 10)
as compared to sham kidneys (Figure 1B). Since TREM-1
protein remains highly expressed during active repair (t = 5)
and that TREM-1+ cells co-localize with Lotus tetragonolobus
lectin (LTL), a proximal tubular marker (Figure 1C), we further
investigated the role of TREM-1 in tissue repair. We adopted
a murine model of genetic deletion which simulate the human
TREM-1 system regulation, where TREM3 appears to be a
pseudogene: the TREM1/3 double KO mice, which underwent
bilateral IR together with WT animals.
TREM1/3 KO animals displayed increased mortality during
the recovery phase compared to WT mice (Figure 1D),
although renal function and inflammatory parameters,
such as keratinocyte chemoattractant (KC) and monocyte
chemoattractant protein-1 (MCP-1) (Table 1) were unchanged
in both animal strains in sham or day 1-5 post-IR. Infiltration
of inflammatory cells such as granulocytes and macrophage was
also similar between animal strains (data not shown).
To avoid mortality, we switched to a milder model
of AKI (unilateral clamping of renal artery for 20min).
We observed that, compared to WT animals, mice lacking
TREM1/3 displayed increased tubular damage 10 days post-IR,
through histopathological assessment of PAS-D-stained sections
(Figure 1E and Supplementary Figure 1A) and evaluation of
tubular injury markers, such as Kim-1 and Ngal (Figures 1F,G).
As this is indicative of impaired repair that could eventually
lead to renal fibrosis (27), we looked at renal macrophage
infiltration, well-known to facilitate tubular repair but, if
persistent, may further boost inflammation and drive fibrosis
(28). Renal tissue from TREM1/3 KO mice showed increased
infiltration of F4/80+ macrophages, compared to WT animals
at t=10 (Figure 1H). The excessive macrophage infiltrate
was also associated with the development of fibrosis, as
reflected by an increase in α-SMA+ myofibroblasts and
collagen type-1 deposits, detected also by picro-sirius red
(PSR) (Figures 1I,J and Supplementary Figure 1B). Besides
these detrimental effects, absence of TREM1/3 also resulted
in impaired tubular regeneration due to the accumulation
of senescent cells, as shown by SA-β-Galactosidase+ TECs,
a common marker for senescence (29) (Figure 1K). In line,
transcript levels of cyclin-dependent kinase inhibitor 1A
(Cdkn1a/p21), which is upregulated in cell-cycle arrest and
senescence (6), appear to be increased in KO animals at t= 10 as
well as in sham-operated mice, when compared to WT animals
(Figure 1L). This is likely to be linked to the decreased TECs
proliferation observed in KO animals, detected by Ki67 staining,
already in sham conditions but also after IR (Figure 1M). Tubular
apoptosis is also associated with fibrosis in the kidney, but
cleaved-caspase-3+ TECs revealed no differences between WT
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FIGURE 1 | TREM-1 limits the maladaptive repair following renal IR injury. (A) Plasma TREM-1 concentration and (B) TREM-1 protein levels in kidney lysates from
sham-operated mice and WT mice subjected to bilateral IR (25min clamping) and sacrificed at day 1, 5, and 10 post-surgery. (C) Representative pictures of
(Continued)
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FIGURE 1 | immunofluorescence staining on kidney tissue from WT mice in sham-operated conditions and 5 days post-IR, with TREM-1 (red) and lotus
tetragonolobus lectin (LTL: proximal tubule marker) in green. (D) Survival graph of WT and TREM1/3 KO mice subjected to bilateral IR for 25min (=severe AKI).
(E) Quantification of tubular injury obtained by histopathological scoring of PAS-D-stained, paraffin-embedded, renal sections from WT and TREM1/3 KO animals
sacrificed at day 1, 5, and 10 post-unilateral IR (=mild AKI). Representative pictures of WT and TREM1/3 KO animals at day 10 post-IR. (F,G) Renal expression of
tubular injury markers Kim1 and Ngal measured by RT-PCR in tissue isolated from sham WT, WT and TREM1/3 KO mice sacrificed 1, 5, and 10 days post-IR.
(H) Quantification of immunohistochemical staining and representative pictures for macrophages (F4/80), (I) myofibroblasts (α-SMA) and (J) collagen type-1 deposits
in WT and TREM1/3 KO mice 10 days post-surgery (magnification 40X). (K) Quantification and representative pictures of SA-β-Gal staining in WT and TREM1/3 KO
mice 10 days post-surgery (magnification 40X). (L) Transcript expression of renal cdkn1a (p21) in WT and KO mice in sham conditions and post-IR. (M) Quantification
of TECs proliferation detected by Ki67 immunohistochemical staining in WT and TREM1/3 KO mice in sham conditions and 1 and 5 days post-surgery. Representative
pictures of WT and TREM1/3 KO kidneys at day 5 (magnification 20X). (N) Quantification of tubular apoptosis detected by cleaved-caspase-3 immunohistochemical
staining in WT and TREM1/3 KO mice in sham conditions and post-IR. Data are expressed as mean ± SEM. (A,B) Kruskal–Wallis and Dunn’s multiple comparison
test, (D) Log-rank (Mantel-Cox) test. (E–N) One way Anova followed by Mann–Whitney test were used to determine statistical differences. *P < 0.05, **P < 0.01,
***P < 0.001.
TABLE 1 | Renal Inflammation in WT and TREM1/3 KO mice upon severe AKI
(N = 8 mice per group).
KC (pg/mg protein) MCP1 (pg/mg protein)
WT TREM1/3 KO WT TREM1/3 KO
Sham 756 ± 104 659 ± 89 22 ± 3 18 ± 2
t = 1 1318 ± 153 1635 ± 90 27 ± 2 34 ± 4
t = 5 831 ± 174 1432 ± 379 54 ± 12 71 ± 21&
KC and MCP-1 levels were measured by ELISA. Values are expressed as mean ± SEM.
&N = 5 mice/group. The t = 10 time point was not included in this table as the number
of surviving KO animals was significantly decreased compared to that of WT mice (WT: n
= 8 vs. TREM1/3 KO: n = 3).
and KO animals post-IR (Figure 1N), suggesting that apoptosis
is not involved in this maladaptive process. Taken together, these
in vivo evidences suggest that the TREM1/3 deficiency results in
a maladaptive repair after AKI.
TREM1/3-Deficient TECs Display G2/M
Arrest and Impaired Energy Metabolism
Since we observed an overall decrease in TECs proliferation
in KO animals and given that tubular proliferation is essential
for regeneration post-IR (3, 4), we aimed to investigate
TREM1/3’s role in tubular response after IR. Therefore, we
evaluated TREM-1 expression in TECs following the in vitro
hypoxia/reoxygenation injury, to model the hypoxic damage
experienced by the TECs during IR. TREM-1 increases in
TECs during re-oxygenation compared to normoxic cells
(Figures 2A–C), suggesting a role for TREM-1 in TEC’s response
to hypoxic damage.
The in vivo study also revealed a decreased proliferation of
TECs in KO animals already in sham conditions. Consistent
with this observation, an increased percentage of phosphorylated
Ser-10 of histone H3 (pH3) nuclei was detected in TREM1/3
KO primary TECs at steady state, indicative of G2/M-arrest
(Figures 3A, 6). Metabolically, cells rely more on oxidative
phosphorylation (OXPHOS) than glycolysis to enter into mitosis
(30). We, therefore, examined the oxygen consumption rate
(OCR) using the Seahorse respirometer. TECs lacking TREM1/3
showed a significant down-regulation in oxidative metabolism,
as both basal and non-mitochondrial respiration levels were
decreased. Accordingly, the lack of TREM1/3 impaired the
ability to maximize OXPHOS usage and cope with sudden
high-energy demand given by the mitochondrial respiration
uncoupler FCCP and by the lower spare capacity. In addition,
the OCR rate associated with ATP production, calculated
after administration of the ATP synthase inhibitor oligomycin,
was also reduced in TREM1/3 KO TECs (Figure 3B). Similar
results were obtained using an immortalized TEC cell line
where only TREM-1 expression was silenced by CRISPR/Cas9
technology. Absence of TREM-1 solely resulted in delayed
G2/M progression and reduced mitochondrial respiration
(Supplementary Figures 2A,B). These results suggest that even
if TREM-3 may play a similar role in tubular proliferation
and oxidative metabolism, this might not be so relevant. To
directly demonstrate the impact of TREM1/3 deficiency on
TEC metabolism, we performed mass spectrometry analysis
of cellular metabolites. TREM1/3 absence has an important
effect on tubular energy metabolism in general, as shown
by the dissimilarities in metabolite content distribution in
the PCA 2D score plot (Figure 3C). As displayed in the
heatmap (Figure 3D), lack of TREM1/3 also results in an overall
reduction in key intermediates of the glycolytic, tricarboxylic
acid (TCA) and pentose phosphate pathway (PPP). Thus,
the effect of TREM1/3 absence, compared to WT cells, may
not be restricted to OXPHOS. Interestingly, the levels of the
antioxidants glutathione (GSH) and oxiglutathione (GSSG) were
increased in KO TECs suggesting an enhanced activity of
mitochondrial defense systems against reactive oxygen species
(ROS) accumulation (Figure 3D).
Hence, these data suggest that TREM-1 may be an
immune-sensor that controls energy metabolism and promotes
TEC proliferation.
TREM1/3 Promotes Tubular Homeostasis
After Hypoxia, by Preserving Mitochondrial
Integrity
From previous evidences obtained in bone marrow-derived
macrophages, we know that TREM-1 plays a role in
mitochondrial integrity (17). Additionally, the increased
antioxidant levels detected in TREM1/3 KO TECs suggest
an impaired control of redox balance, which could lead to
higher ROS levels and impact mitochondrial energy metabolism
(31). An in-depth analysis of mitochondria following the
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FIGURE 2 | TREM-1 is expressed in TECs upon hypoxia-reoxygenation (A). Representative immunofluorescent images of IM-TECs cultured on coverslips in normoxia
conditions and after hypoxia-reoxygenation. Cells were stained with TREM-1 (Alexa 594, red) and Hoechst (nuclei). (B) Mean Fluorescence intensity (MFI) of TREM-1
membrane expression measured by flow cytometry. (C) Protein lysates of the same experiment blotted for anti-TREM-1 Ab and β-actin. In (B,C) data are expressed
as mean ± SEM and the unpaired t-test was used to determine statistical differences. N = 5–6 animals/group. *P < 0.05, **P < 0.01.
hypoxia/re-oxygenation model we adopted in vitro, revealed
an aberrant mitochondrial homeostasis in TREM1/3 KO TECs.
To gain more insight into the morphology, we looked at the
expression of the translocase of outer membrane 20 (TOM20),
a mitochondrial marker, which clearly showed rounded and
fragmented mitochondria in TREM1/3 KO TECs, as compared
to the typical filamentous network of mitochondria observed
in WT cells, already in normoxic conditions. This altered
morphology worsened during re-oxygenation conditions
(Figure 4A) and was also displayed by WB analysis, where
a decrease in protein content was evident in KO primary
TECs (Figure 4B).
TREM1/3 deficiency was also associated with increased
mitochondrial superoxide production, detected by the
Mitosox probe, both in normoxic and hypoxia/re-
oxygenation conditions (Figure 4C). Further analysis of
mitochondrial function revealed an impressive mitochondrial
depolarization, detected with a dual-fluorescence emission
mitochondrial membrane potential-sensor (Figure 4D).
Consequently, the mitochondrial dysfunction was associated
with a decrease in ATP production in TREM1/3 KO
TECs, compared to WT cells, under both experimental
conditions (Figure 4E). Pgc1a, Tfam, phospho-AMPK
and Mitofusin-2 expression was found to be similar
in WT and TREM1/3 KO TECs, indicating that the
impaired mitochondrial homeostasis was not associated
with any differences in mitochondrial biogenesis or
dynamics (Supplementary Figures 3A–C).
Altogether, these data suggest that the innate immune
receptor TREM1/3 preserves mitochondrial homeostasis in
TECs, possibly by limiting ROS production.
Hypoxia-Induced Oxidative Stress Induces
a Senescent Phenotype in TREM1/3 KO
Primary TECs
ROS-induced mitochondrial dysfunction can contribute to the
development of senescence. With this in mind, we observed
tubular senescence in vivo after IR and checked whether
TREM1/3 KO TECs subjected to hypoxia-reoxygenation could
become senescent. By FACS analysis, we looked at C12FDG-
positive cells (a fluorescent substrate for β-galactosidase, only
retained in senescent cells). The oxidative stress induced by
the hypoxic conditions, drove only TREM1/3 KO TECs into
a senescent state, as shown by FACS and microscopic analysis
(Figures 5A,B). Additionally, TREM1/3 KO TECs displayed
increased levels of p21WAF1/CIP1 protein, under both normoxia
and re-oxygenation (Figure 5C), suggesting that the effects of
mitochondrial dysfunction and ROS production in KO cells may
be mediated through p21. G2/M-arrested and senescent TECs
release inflammatory and pro-fibrotic mediators, components
of the senescence-associated secretory phenotype (SASP), to
further exacerbate renal inflammation and fibrosis (6, 32).
Accordingly, already under normoxic conditions, KO TECs
displayed an increased secretory phenotype, characterized by
higher transcription of pro-inflammatory and pro-fibrotic genes,
including Il6 and Il1a, Tgfb, Vegf, and Ctgf compared to WT
TECs (Figures 5D–I). To investigate whether increased ROS
production was the root of senescence, we measured several
antioxidants. The relative abundance of total glutathione was
actually increased in KO TECs in both experimental conditions,
whereas the gene expression of glutathione peroxidase 1-3 (Gpx1-
3) and peroxiredoxin-1 (Prdx1) only increased in KO TECs
during re-oxygenation. Superoxide dismutase 2 (Sod2) mRNA
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FIGURE 3 | TREM1/3 KO primary TECs display arrest in G2/M and reduced mitochondrial metabolism at steady state. (A) Representative immunofluorescent images
of primary TECs at steady state isolated from WT and TREM1/3 KO animals (n = 5) (magnification 40X). Cells were stained with Hoechst (nuclei), anti-Ki67
(Continued)
Frontiers in Immunology | www.frontiersin.org 9 July 2019 | Volume 10 | Article 1469
Tammaro et al. TREM1/3 in Tissue Repair
FIGURE 3 | (proliferating cells), Alexa 594 and anti-phosphorylated histone H3(ser10)- Alexa 488-conjugated (to identify cells in G2/M). Quantification of percentage of
phosphorylated histone H3 positive nuclei per HPF. (B) Seahorse Bioanalyzer OCR readout of a typical mitochondrial function assay using WT and TREM1/3 KO
primary TECs without adjustment for cell number. AA, antimycin A; rot, rotenone. Conditions were measured in triplicate. The bar graphs represent data adjusted for
cell input for WT and TREM1/3 KO primary TECs. (C) Principal component analysis (PCA) of intracellular metabolite levels from WT and TREM-1/3 KO primary TECs
at steady state (CTR) as determined by LC-MS (metabolomics) (n = 5/6 mice per group). (D) Differences in metabolic pathways are displayed by the heatmap.
(A,B) All data are expressed as mean ± SEM and the unpaired t-test was used to determine statistical differences. *P > 0.05, **P < 0.01, ***P < 0.001.
FIGURE 4 | TREM1/3 deficient TECs display an altered mitochondrial homeostasis. (A) Representative immunofluorescent images of primary TECs stained for
mitochondrial protein TOM20 (Alexa488) and Hoechst (nuclear staining), under normoxic conditions and 24 h after re-oxygenation (magnification 100X) (N = 3 animals
per conditions). (B) Western blot of WT and TREM1/3 KO primary TECs blotted for TOM20 and β-actin. (C) Mitochondrial ROS production measured by FACS
analysis with MitoSox probe. Histogram representation of Mitosox events expressed as % of max. (N = 5 animals per group). (D) Mitochondrial polarization measured
by cationic dual-emission fluorescent probe, expressed as a ratio between red (mitochondria, J-aggregates) and green (cytoplasm, dye monomers) fluorescence
intensity. Results are expressed as a ratio of red and green fluorescence emission. (N = 5 animals per group). (E) ATP production in protein lysates of WT and
TREM1/3 KO primary TECs, corrected for the total protein concentration measured by BCA (N = 5/6 animals per group). All data are expressed as mean ± SEM and
the unpaired t-test was used to determine statistical differences. *P < 0.05, **P < 0.01, ***P < 0.001.
levels, instead, were unchanged, suggesting that detoxification
of hydrogen peroxide, but not O−2 , is affected in KO TECs
(Figures 5J–N). Additionally, no change in Cytc were measured
between WT and KO cells (Figure 5O). This, together with
the absence of differences in caspase-3+TECs in vivo, may
exclude a role for TREM1/3 in ischemic/oxidative stress-
induced apoptosis.
It is likely that the mitochondrial dysfunction in KO TECs
have impacted the response to IR in the in vivo study. Indeed
we found that kidneys from KO animals show a metabolic
reprogramming toward glycolysis, assessed by the increased
expression of the glycolytic pyruvate kinase isozymes M2
(PKM2) protein, both in contralateral and ischemic kidney that
failed to regenerate (Supplementary Figure 4A). To further
support TREM-1’s protective role against senescence, ROS
generation and mitochondrial damage, we used another in vitro
model of oxidative stress, where we exposed primaryWT and KO
TECs to the antineoplastic agent Doxorubicin (DOX), which was
previously reported to induce both senescence andmitochondrial
damage with increased ROS production (33). To avoid cell death
(data not shown), we treated TECs with a low concentration of
DOX (0.1µM). Similar to the result obtained with the hypoxic
damage, lack of TREM1/3 disrupted mitochondrial morphology
(TOM20) (Supplementary Figure 5A), increased intracellular
ROS (Supplementary Figure 5B) and induced senescence
markers (β-gal, p21, SASP) (Supplementary Figures 5C–E),
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FIGURE 5 | TREM1/3 KO TECs display senescence upon hypoxia-derived oxidative stress. (A) FACS analysis of senescence- associated β-galactosidase (SA-βgal)
assay by C12FDG incorporation in WT and TREM1/3 KO primary TECs in normoxia conditions and upon hypoxia/re-oxygenation (N = 5/6). (B) (SA-βgal) staining
obtained in primary WT and TREM1/3 KO TECs in normoxia and hypoxia/re-oxygenation, cultured on coverslips. Blue/green cells represent senescent cells. (C) p21
protein expression shown by western blot in primary TEC lysates isolated from WT and TREM1/3 KO animals during normoxia and hypoxia-reoxygenation.
(D–F) Transcript expression of SASP-components such as pro-inflammatory (Il6, Il1a, Il1b) and (G–I) profibrotic genes (Tgfb, Vegf, and Ctgf ) in WT and TREM1/3 KO
primary TECs under normoxia/re-oxygenation conditions (N = 5). (J–O) Anti-oxidant expression, such as total glutathione, measured by metabolomics, and transcript
expression of glutathione peroxidase 1-2 (gpx1 and gpx3), peroxiredoxin 1 (prdx1), and cytochrome C (CytC), measured by RT-PCR in WT and KO TECs in
normoxia/re-oxygenation conditions (N = 5). (P,Q) Total NAD+ and oxaloacetate levels measured by metabolomics. All data are expressed as mean ± SEM and the
unpaired t-test was used to determine statistical differences. *P < 0.05, **P < 0.01, ***P < 0.001.
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with no effect on mitofusin-2 expression nor AMPK activation
(Supplementary Figures 5F,G). This data suggest a general role
for TREM1/3 in preventing cellular senescence and excessive
ROS accumulation.
Mitochondria metabolites are also impaired during
senescence. Previous reports have linked decreased NAD+
levels with senescence and mitochondrial dysfunction (34).
Thus, we assessed total NAD+ content in TECs and found
significantly decreased NAD+ levels in KO TECs following
hypoxia/re-oxygenation (Figure 5P). This nicely correlates with
the increased β-galactosidase activity associated with senescence
in KO cells (Figure 5A). Besides NAD+, other metabolites of the
TCA cycle can also influence cellular function. Interestingly, we
found that TREM1/3 KO TECs display an aberrant accumulation
of oxaloacetate (OA), a pivotal regulator of the metabolic flux
through the TCA cycle, whose concentration should be tightly
controlled within the mitochondrial matrix to avoid growth
arrest (35) (Figure 5Q).
TREM-1 Modulates “Stress-Induced
Senescence” in TECs
Next, we investigated whether TREM-1 signaling can modulate
the senescence phenotype after hypoxia/re-oxygenation.
TREM-1 ligation by agonistic antibody during re-oxygenation
conditions (24 h) ameliorates the SA-β-galactosidase activity
(Figure 6A) as well as p21 gene expression (cdkn1a) (Figure 6B)
and increased Myd88 gene expression (Figure 6C). As another
feature of senescence is the SASP, we looked at the pro-
inflammatory and pro-fibrotic gene expression. TREM-1
ligation did not have any effect on pro-inflammatory SASP
(Figure 6D) but was able to ameliorate pro-fibrotic gene
expression (Figure 6E).
We reasoned that TREM1/3 KO TECs manifested the
so-called “stress-induced” senescence due to an aberrant
mitochondrial function, accumulation of ROS and p21
activation (36). To prove this, we stimulated cells during
re-oxygenation conditions using a mitochondrially-targeted
oxygen radical scavenger, mitoTEMPO. Incubation of TREM1/3
KO TECs in presence of MitoTEMPO completely prevented
the SA-β-galactosidase activity and cdkn1a gene expression
(Figures 7A,B). Additionally, the pro-fibrotic SASP but not the
pro-inflammatory SASP were also ameliorated in presence of
MitoTEMPO (Figures 7D–F). These data strongly implicate
the mitochondrial dysfunction as cause of ‘stress-induced
senescence’ in absence of TREM-1.
In order to translate these findings into the functional
settings of tissue repair, we subjected WT and KO TECs to
hypoxia/reoxygenation and then performed a wound healing
assay. We measured the wound area (in pixels) at 8, 16, and 24 h
after having scratched the monolayer with a pipette tip. In WT
TECs the gap was completely closed after 24 h, whereas TREM1/3
KO TECs showed a clear delay in wound healing (Figure 8). This
suggests that senescence resulted in impaired wound healing.
Taken together, these data suggest that TREM1/3 deficiency
impairs the mitochondrial metabolic flexibility in TECs which
resulted in tubular senescence and impacted renal regeneration.
Supplementary Figure 6 shows a schematic representation of
our proposed model of TREM1/3-mediated renal repair.
DISCUSSION
Acute kidney injury (AKI) is a major clinical concern that
is considered to be reversible, when not lethal in the acute
phase. More recently, however, even mild episodes of AKI
have been linked to subsequent development of CKD. The
maladaptive repair mechanisms of TECs can be the principal
mediator of this chronic progression. Maladaptive tubular cells
present senescence, manifested as G2/M arrest and increased
SASP. Although innate immune receptors can control cell
fate and behavior through regulation of metabolism, a study
demonstrating the role of innate immune receptors in the
epithelial senescence is still lacking. Herein, we provide novel
evidences that the innate immune receptor TREM1/3 mediates
senescence through immunometabolism. We extended the
knowledge about TREM1/3’s function to the control of the
mitochondrial metabolic activities and as guardian of the redox
balance in tubular cells, which limits senescence. Additionally,
this papers highlights a remarkable role for TEC’s metabolic
flexibility in mediating adaptive renal repair after IR and that
might be under the control of innate immune receptors.
TREM-1 does not play a crucial role in the acute phase
after AKI (12), whereas in a model of renal fibrosis, might
be detrimental due to a direct effect on renal inflammation
and M1 macrophages activation (37). However, the role of
TREM-1 in renal repair following AKI has not yet been
completely unraveled. Herein, we found that renal TREM-
1 protein expression is increased 5 days post-IR and that
TREM1/3 KO animals subjected to a severe model of
AKI show increased mortality during active repair with
no differences in inflammatory parameters, such as pro-
inflammatory cytokines and granulocytes or macrophages
infiltration (data not shown). In a milder model of AKI,
TREM1/3 KO animals show no differences in renal damage 24 h
post-IR, but do display maladaptive repair with persistent tubular
damage, inflammation, fibrosis and tubular senescence. TEC
proliferation is crucial for tubular regeneration after AKI, indeed,
cell cycle arrest is associated with CKD (38). TREM-1 expression
increased in TECs during repair and after hypoxia-reoxygenation
injury in vitro. Considering that TREM-1 is a hypoxia-inducible
gene in DCs and is upregulated in the epithelia of different organs
upon inflammation (39–41), altogether these findings suggest
a role for TREM-1 in TEC recovery after IR. Nevertheless, we
found that TREM1/3-deficiency has profound influence on TECs
metabolism and fate already at steady state, resulting in G2/M
arrest and decreased energy metabolism. Cells sense and respond
to an increase in energy demand for cell cycle progression, but
also a metabolic rewiring during hypoxia, is crucial to return
to metabolic homeostasis. It appears that TREM1/3 KO TECs
due to the metabolic meltdown cannot longer cycle and that
the impaired metabolic flexibility leave them unable to cope
with the sudden energy deprivation experienced during ischemia.
Healthy mitochondria are essential to provide the TECs with
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FIGURE 6 | TREM-1 signaling modulates senescence in TECs. (A) FACS analysis of senescence- associated β-galactosidase (SA-βgal) assay by C12FDG
incorporation in WT primary TECs stimulated with isotype control (CTR) and 10µg/ml TREM-1 agonistic antibody (mTREM-1), during re-oxygenation conditions (24 h)
(N = 5/6 animals per group). (B-C) Relative expression of p21 (cdkn1a) and Myd88 genes in WT TECs in CTR and mTREM-1 conditions, during reoxygenation.
(D) Transcript expression of SASP-components such as pro-inflammatory (Il6, Il1a, Il1b) and (E) profibrotic genes (Tgfb, Ctgf, and Vegf ) in WT TECs under
re-oxygenation conditions stimulated with isotype control and mTREM-1 (N = 5–6 animals/group). All data are expressed as mean ± SEM and the unpaired t-test
was used to determine statistical differences. *P < 0.05, **P < 0.01, ***P < 0.001.
an adequate energy supply. TREM1/3-deficient TECs displayed
an aberrant mitochondrial homeostasis. The ROS produced by
mitochondrial oxidative metabolism are buffered intracellularly
by redox cycling systems, such as GSH/GSSG; however, if ROS
production exceeds the cell’s buffering abilities, oxidative stress
and mitochondrial damage can occur (42, 43). It is conceivable
that the impaired ability to carry out many metabolic functions
observed in the TREM1/3 KO TECs, is due to oxidative damage
and that the increased levels of anti-oxidants detected are simply
an adaptive response to avoid cell death.
Quiescent TECs rely mostly on oxidative phosphorylation,
thus we reasoned that the aberrant mitochondrial phenotype in
KO TECs could lead to a metabolic reprogramming. Indeed, in
the in vivo study we observed that KO animals that presented
a maladaptive repair with increased TECs senescence, displayed
a metabolic reprogramming toward glycolysis, most likely due
to mitochondrial pathology, as previously reported in TECs that
failed to regenerate (10).
TREM-1 preserves mitochondrial integrity in bone marrow-
derived macrophages, through Mitofusin-2, promoting
mitochondrial fusion and inhibiting apoptosis (17). Despite
this evidence, no differences in macrophage infiltration were
found at basal conditions and early after renal IR, in both severe
and mild AKI (data not shown), whereas TECs proliferation was
decreased in both severe and mild AKI experiments suggesting
that TECs, rather than macrophage infiltration, are most likely
responsible for the impaired repair. Additionally, in contrast
to previous reports in macrophage, in our model using TECs,
mitochondrial dynamics and biogenesis are not affected in
TREM1/3 KO TECs (44).
Disturbed mitochondrial homeostasis and excessive
ROS production can predispose cells to “stress induces
senescence” (42, 43, 45). When TREM1/3 KO TECs were
exposed to two different ROS-generating triggers, such as
hypoxia/reoxygenation or doxorubucin, this was sufficient to
drive the cells into a senescent state. Cell cycle arrest and “stress-
induced senescence” involve activation of cyclin-dependent
kinases, in order to recognize and repair genetic defects (46). p21
is involved in the G2 checkpoints and its activation is linked to
cell cycle arrest and senescence (47). In line with these studies,
TREM1/3 KOTECs displayed increased p21 activation in control
conditions and after exposure to ROS triggers. Mice deficient
for p21 are protected against renal dysfunction and fibrosis
after renal ablation (48). Apparently, senescence is important
for wound healing but accumulation of senescent cells delays
regeneration, just as it happened in our in vivo model. Given
the fact that a mitochondrial antioxidants (mitoTEMPO) was
able to reverse senescence and the pro-fibrotic phenotype in KO
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FIGURE 7 | MitoTEMPO partly prevented stress-induced senescence in TREM1/3 KO TECs. (A) FACS analysis of senescence- associated β-galactosidase (SA-βgal)
assay by C12FDG incorporation in WT and TREM1/3 KO primary TECs stimulated MitoTEMPO (100µM) during re-oxygenation conditions (24 h) (N = 5/6 animals per
group). (B) p21 (cdkn1a) relative expression after stimulation with MitoTEMPO during reoxygenation in WT and TREM1/3 KO TECs. (C) Transcript expression of
SASP-components such as pro-inflammatory (Il6, Il1a, Il1b) and (D–F) profibrotic genes (Tgfb, Ctgf, and Vegf ) in TREM1/3 KO primary TECs under re-oxygenation
conditions stimulated with MitoTEMPO (N = 5–6 animals/group). All data are expressed as mean ± SEM and the unpaired t-test was used to determine statistical
differences. *P < 0.05, **P < 0.01, ***P < 0.001.
FIGURE 8 | TREM1/3 KO TECs display impaired wound healing capacity after hypoxia-reoxygenation. 24 h after re-oxygenation, the epithelial monolayer of WT and
TREM1/3 KO TECs was damaged by a scratch with a p100 pipette tip. (A) The damaged area is shown in the pictures taken with a contrast-phase microscope at
t = 0 and 24 h later. Every 8 h, for up to 24 h, (B) the damaged area (shown in pixels) was measured with an in-house software (ci-Micro), developed by the department
of cell biology and histology at our institution. All data are expressed as mean ± SEM (n = 5) and the unpaired t-test was used to determine statistical differences.
*P < 0.05, **P < 0.01.
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TECs, this would further support our hypothesis that TECs in
TREM1/3 KO animals display stress-induced senescence which
most likely would be the root cause of maladaptive repair and
fibrosis. TREM1/3 KO TECs displayed also increased SASP,
which could possibly influence the renal microenvironment and
create a vicious fibrotic cycle, that hinder renal regeneration and
exacerbate fibrosis, as previously described (6). Altogether, these
observations indicate that in the absence of TREM1/3, TECs
are in G2/M arrest and that IR leads to a permanent growth
arrest, manifested as senescence, which results in impaired
wound healing.
The profound impact of TREM1/3 absence in TEC’s
metabolism have been further confirmed by the aberrant
accumulation of the mitochondria metabolite oxaloacetate (OA)
already at steady state, but also by the NAD+ decline during
reoxygenation conditions. The latter might be simply explained
by the oxidative stress-induced mitochondrial dysfunction,
known to affect this metabolite (34, 49). OA instead, derives
from the TCA cycle and participates in the metabolism of
energy production and recent research has shown that is
affected during cell cycle disturbance. Moreover, OA enhances
mitochondrial metabolism by potentiating OXPHOS (50). Thus,
accumulation of OA could reflect the decreased flux through the
TCA cycle or the attempt of enhancing OXPHOS in TREM1/3
KO TECs.
Despite the fact that we have demonstrated a link between
TREM-1 pathway, mitochondrial energy metabolism and
senescence, we remain unaware of the exact trigger for TREM-1
activation in this model and how an innate immune receptor
present in the plasma membrane can affect mitochondrial
homeostasis. Surely, the identification of the TREM-1 ligand
in TECs and in the context of IR would help to clarify the
mechanism, but this still represents a limitation within TREM-1
research and thus of this study (13).
Finally, this study extends the novel link between innate
immunity and tubular metabolism (19), including epithelial
senescence. Although it is evident that senescence delays tissue
repair and increases the risk of AKI-CKD progression, studies
focused on the immunometabolic reprogramming that occurs
in tubular senescent cells are at a very early stage. Here, we
propose that the innate immune receptor TREM-1, is able
to affect mitochondrial function in TECs, which regulates
energy metabolism and limits senescence. In this way, TREM-
1 might supply TECs with the metabolic flexibility necessary to
promote proliferation and regeneration in the tubular epithelium
after AKI.
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